The early evaluation of survivors after extracorporeal membrane oxygenation for neonatal pulmonary failure

Area of Science:

• Neonatal care
• Pediatric critical care
• Extracorporeal life support

Background:

• Limited data exists on the long-term development of neonates surviving extracorporeal membrane oxygenation (ECMO).
• Assessing post-ECMO outcomes is crucial for understanding the benefits and risks of this life-saving intervention in newborns with fatal pulmonary failure.

Purpose of the Study:

• To evaluate the physical, neurological, and psychologic development of neonates who survived ECMO for severe pulmonary failure.
• To provide early insights into the outcomes of neonatal ECMO survivors to support its wider application.

Main Methods:

• Follow-up examinations of nine neonates surviving ECMO at 15 to 21 months post-treatment.
• Evaluations included physical growth, chest X-rays, arterial blood gases, echocardiograms, cerebrovascular dopplers, CT scans, EEGs, neurologic surveys, and psychologic assessments.

Main Results:

• Six of nine survivors exhibited normal physical growth and development.
• Pulmonary parenchyma, arterial blood gases, and echocardiograms were normal in most survivors; no pulmonary hypertension was detected.
• Neurologic assessments were normal in five patients; one experienced cerebral atrophy after an air embolus. All survivors had normal psychologic examinations.

Conclusions:

• Neonates surviving ECMO for predictably fatal pulmonary failure demonstrate positive early development.
• These findings support the expanded use of ECMO in critically ill newborns who would otherwise have a fatal outcome.